IL210313A0 - Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology - Google Patents

Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology

Info

Publication number
IL210313A0
IL210313A0 IL210313A IL21031310A IL210313A0 IL 210313 A0 IL210313 A0 IL 210313A0 IL 210313 A IL210313 A IL 210313A IL 21031310 A IL21031310 A IL 21031310A IL 210313 A0 IL210313 A0 IL 210313A0
Authority
IL
Israel
Prior art keywords
active substance
therapeutically active
medical technology
silica gel
resorbable
Prior art date
Application number
IL210313A
Other languages
English (en)
Original Assignee
Bayer Innovation Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Innovation Gmbh filed Critical Bayer Innovation Gmbh
Publication of IL210313A0 publication Critical patent/IL210313A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/62227—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products obtaining fibres
    • C04B35/62231—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products obtaining fibres based on oxide ceramics
    • C04B35/6224—Fibres based on silica
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/06—Preparatory processes
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/40—Metallic constituents or additives not added as binding phase
    • C04B2235/408—Noble metals
    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30—Constituents and secondary phases not being of a fibrous nature
    • C04B2235/44—Metal salt constituents or additives chosen for the nature of the anions, e.g. hydrides or acetylacetonate
    • C04B2235/441—Alkoxides, e.g. methoxide, tert-butoxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Ceramic Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Structural Engineering (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Polymers (AREA)
  • Inorganic Fibers (AREA)
  • Silicon Compounds (AREA)
IL210313A 2008-07-16 2010-12-28 Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology IL210313A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008033327A DE102008033327A1 (de) 2008-07-16 2008-07-16 Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik
PCT/EP2009/004806 WO2010006708A1 (de) 2008-07-16 2009-07-03 Kieselsol-material mit mindestens einem therapeutisch aktiven wirkstoff zur herstellung von biologisch degradierbaren und/oder resorbierbaren kieselgel-materialen für die humanmedizin und/oder medizintechnik

Publications (1)

Publication Number Publication Date
IL210313A0 true IL210313A0 (en) 2011-03-31

Family

ID=41011815

Family Applications (1)

Application Number Title Priority Date Filing Date
IL210313A IL210313A0 (en) 2008-07-16 2010-12-28 Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology

Country Status (13)

Country Link
US (1) US20110123596A1 (noticia-042933_Expedia:--La-mitad-de-los-viajeros-reservan-a-traves-de-las-OTA-y-es-una-tendencia-creciente--.html)
EP (1) EP2303948B1 (noticia-042933_Expedia:--La-mitad-de-los-viajeros-reservan-a-traves-de-las-OTA-y-es-una-tendencia-creciente--.html)
JP (1) JP2011527913A (noticia-042933_Expedia:--La-mitad-de-los-viajeros-reservan-a-traves-de-las-OTA-y-es-una-tendencia-creciente--.html)
KR (1) KR20110039533A (noticia-042933_Expedia:--La-mitad-de-los-viajeros-reservan-a-traves-de-las-OTA-y-es-una-tendencia-creciente--.html)
CN (1) CN102159623A (noticia-042933_Expedia:--La-mitad-de-los-viajeros-reservan-a-traves-de-las-OTA-y-es-una-tendencia-creciente--.html)
AU (1) AU2009270515A1 (noticia-042933_Expedia:--La-mitad-de-los-viajeros-reservan-a-traves-de-las-OTA-y-es-una-tendencia-creciente--.html)
BR (1) BRPI0915946A2 (noticia-042933_Expedia:--La-mitad-de-los-viajeros-reservan-a-traves-de-las-OTA-y-es-una-tendencia-creciente--.html)
CA (1) CA2730697C (noticia-042933_Expedia:--La-mitad-de-los-viajeros-reservan-a-traves-de-las-OTA-y-es-una-tendencia-creciente--.html)
DE (1) DE102008033327A1 (noticia-042933_Expedia:--La-mitad-de-los-viajeros-reservan-a-traves-de-las-OTA-y-es-una-tendencia-creciente--.html)
IL (1) IL210313A0 (noticia-042933_Expedia:--La-mitad-de-los-viajeros-reservan-a-traves-de-las-OTA-y-es-una-tendencia-creciente--.html)
MX (1) MX2011000475A (noticia-042933_Expedia:--La-mitad-de-los-viajeros-reservan-a-traves-de-las-OTA-y-es-una-tendencia-creciente--.html)
RU (1) RU2512512C2 (noticia-042933_Expedia:--La-mitad-de-los-viajeros-reservan-a-traves-de-las-OTA-y-es-una-tendencia-creciente--.html)
WO (1) WO2010006708A1 (noticia-042933_Expedia:--La-mitad-de-los-viajeros-reservan-a-traves-de-las-OTA-y-es-una-tendencia-creciente--.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010008982A1 (de) * 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie
DE102010008981A1 (de) * 2010-02-24 2011-08-25 Bayer Innovation GmbH, 40225 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie
DE102010023336A1 (de) * 2010-06-10 2011-12-15 Bayer Innovation Gmbh Verfahren zur Herstellung eines Kieselsol-Materials
RU2541949C2 (ru) 2010-07-02 2015-02-20 Дзе Проктер Энд Гэмбл Компани Филаменты, содержащие активный агент, нетканые полотна и способы их получения
CA2803636C (en) 2010-07-02 2017-05-16 The Procter & Gamble Company Detergent product and method for making same
EP2588655B1 (en) 2010-07-02 2017-11-15 The Procter and Gamble Company Method for delivering an active agent
EP2588659B1 (en) * 2010-07-02 2016-03-16 The Procter and Gamble Company Filaments comprising an ingestible active agent nonwoven webs and methods for making same
WO2012131095A1 (en) * 2011-03-31 2012-10-04 Galderma Research & Development Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material
FI20155779A (fi) * 2015-10-30 2017-05-01 Solani Therapeutics Ltd Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu
JP6882519B2 (ja) 2017-01-27 2021-06-02 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 発泡性凝集粒子を含む溶解性固形構造体形態の組成物
MX386124B (es) 2017-05-16 2025-03-18 Procter & Gamble Composiciones acondicionadoras para el cuidado del cabello en la forma de estructuras sólidas solubles.
DE102017009989A1 (de) * 2017-10-26 2019-05-02 Carl Freudenberg Kg Biokompatibles Verbundmaterial zum Einbringen in einen menschlichen Körper
US20190255223A1 (en) * 2018-02-16 2019-08-22 American Nano, LLC Silica fiber compositions and methods of use
CN108283707B (zh) * 2018-04-05 2021-03-26 广西中医药大学 一种瑶药退烧贴及其制备方法
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
WO2020264574A1 (en) 2019-06-28 2020-12-30 The Procter & Gamble Company Dissolvable solid fibrous articles containing anionic surfactants
US11925698B2 (en) 2020-07-31 2024-03-12 The Procter & Gamble Company Water-soluble fibrous pouch containing prills for hair care
CN113332488A (zh) * 2021-05-31 2021-09-03 南昌智产科技有限公司 一种医用硅凝胶泡沫敷料及其制备方法
CN114404660A (zh) * 2022-01-21 2022-04-29 江苏信立康医疗科技有限公司 一种基于三维支架的细胞培养方法
CN115531592A (zh) * 2022-10-27 2022-12-30 李升红 一种实现皮肤高效修复的皮肤敷料及其制备方法
DE102023208022A1 (de) * 2023-08-22 2025-02-27 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Kieselsäure freisetzende faser oder faserfragmente, hieraus hergestellte faservliese sowie formulierung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19609551C1 (de) 1996-03-12 1997-07-17 Fraunhofer Ges Forschung Biologisch degradierbare und/oder biologisch resorbierbare (Endlos)Fasern, Verfahren zu deren Herstellung und deren Verwendung als Verstärkungsfasern
US6764690B2 (en) * 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
DE69733889T3 (de) * 1996-05-29 2009-10-22 Delsitech Oy Lösliche oxide für biologische anwendungen
US6395299B1 (en) * 1999-02-12 2002-05-28 Biostream, Inc. Matrices for drug delivery and methods for making and using the same
DE60035672T2 (de) * 1999-02-22 2008-04-30 Delsitech Oy Biologisch abbaubare silicafasern aus einem silicasol
US7118921B1 (en) * 1999-06-24 2006-10-10 Mcmaster University Incorporation and applications of biomolecular interactions within a carrier
CA2377560C (en) * 1999-06-24 2010-08-24 Mcmaster University Incorporation and applications of biomolecular interactions within a carrier
DE10126137C1 (de) * 2001-05-29 2002-11-07 Andreas Haisch Verfahren zur Herstellung von Zellen, Geweben und Organen
DE102004063599B4 (de) 2004-12-30 2007-07-12 Bayer Innovation Gmbh Verkürzte Wundheilungsprozesse mittels neuartiger Faservliese
DE102007061873B4 (de) * 2007-01-15 2025-06-26 Bayer Intellectual Property Gmbh Kieselsol-Material zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien, dessen Herstellung und Verwendung
US8114320B2 (en) * 2007-01-16 2012-02-14 Basf Se Method for producing polymer particles by the polymerization of fluid drops in a gas phase

Also Published As

Publication number Publication date
RU2011105299A (ru) 2012-08-27
EP2303948B1 (de) 2018-09-12
US20110123596A1 (en) 2011-05-26
JP2011527913A (ja) 2011-11-10
RU2512512C2 (ru) 2014-04-10
AU2009270515A1 (en) 2010-01-21
WO2010006708A1 (de) 2010-01-21
KR20110039533A (ko) 2011-04-19
DE102008033327A1 (de) 2010-01-21
MX2011000475A (es) 2011-03-15
EP2303948A1 (de) 2011-04-06
CN102159623A (zh) 2011-08-17
CA2730697A1 (en) 2010-01-21
CA2730697C (en) 2016-10-25
BRPI0915946A2 (pt) 2019-04-09

Similar Documents

Publication Publication Date Title
IL210313A0 (en) Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology
IL221806A0 (en) Silica sol material for producing biologically degradable and/or resorbable silica gel materials, the production and use thereof
IL218945A (en) Scaffolding material for wound treatment and / or for other healing applications
ZA200709716B (en) Resorbable polyether esters and use thereof for producing medical implants
EP2219572A4 (en) RESORBABLE HEMOSTATIC STRUCTURES ENHANCED BY NANOMATERIAL AND BANDING MATERIALS
IL206080A0 (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
IL190452A0 (en) Short term sustained drug-delivery system for implantable medical devices and method of making the same
BRPI1010836A2 (pt) nutrição medicinal especializada para pacientes cirúrgicos e de trauma contendo probióticos
ZA201200111B (en) Pharmaceutical composition for use medical and veterinary ophthalmology
EP2059183A4 (en) BIOMEDICALLY ACTIVE NANOTHERAPY WITH ENERGY ACTIVATION INCLUDING DENTAL AND MEDICAL TREATMENTS AND INTERVENTIONS
EP1865882A4 (en) DEGRADABLE IMPLANTABLE MEDICINE PRODUCTS
BRPI0819575A2 (pt) "bandagens médicas e kit de bandagem médica"
FI20065297L (fi) Bioabsorboituva muotoutuva fiksaatiomateriaali ja -implantti
PL3064579T3 (pl) Kompozycje farmaceutyczne i zastosowania medyczne uzyskanych metodami inżynierii ludzkich arginaz
IL207546A (en) Medical compounds for use in the treatment or prevention of bone and joint disease
IL210810B (en) Peptides to treat pain and/or inflammation
IL211694A (en) Products containing anti-conxinic substances and their use to alter the treatment effect of psychotropic drugs
EP2074661A4 (en) USE OF QUANTUM SYSTEM IDENTIFICATION AND QUANTUM CONTROL TECHNOLOGIES FOR MEDICAL DIAGNOSIS AND THERAPEUTIC PURPOSES
EP2417989A4 (en) MEDICAL MATERIAL FOR IN VIVO IMPLANTATION CONTAINING SOFTENER AND / OR MOISTURIZING AGENT, METHOD FOR CONTROLLING SOFTENER AGENT CONTENT AND / OR MOISTURIZING AGENT OF SAID MEDICAL MATERIAL, AND PROCESS FOR PRODUCING MEDICAL MATERIAL FOR IMPLANTATION IN VIVO
IL205290A (en) A variant of human neurorthin protein, or its active biological part, containing medicinal preparations, and its use in the preparation of therapeutic drugs
GB0603612D0 (en) Medical wound healing treatment
EP2099465A4 (en) IMPROVEMENT BY REISHI OF HUMAN TISSUE PROGENITOR CELLULAR ADHESION AND DIFFERENTIATION
GB0603630D0 (en) Medical wound healing treatment
ZA201001825B (en) Increasing the in vivo biological activity of biologically active compounds
EP2381963A4 (en) MEDICAL DEVICE WITH FORMULATIONS FOR TARGETED DELIVERY OF A BIOLOGICALLY ACTIVE SUBSTANCE (SUBSTANCES) AND METHOD OF MANUFACTURING THE SAME